e-learning
resources
ERJ
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
The cancer hypothesis of pulmonary arterial hypertension: are polyamines the new Warburg?
Christopher J. Rhodes
Source:
Eur Respir J, 56 (5) 2002350; 10.1183/13993003.02350-2020
Journal Issue:
November
Disease area:
Pulmonary vascular diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Christopher J. Rhodes. The cancer hypothesis of pulmonary arterial hypertension: are polyamines the new Warburg?. Eur Respir J, 56 (5) 2002350; 10.1183/13993003.02350-2020
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
The definition of pulmonary hypertension: history, practical implications and current controversies
Patient with ankylosing spondylitis and pulmonary hypertension
CARDIAC DYSFUNCTION IN ACTIVE PULMONARY TUBERCULOSIS: DOUBLE TROUBLE!!
Related content which might interest you:
Is there an obesity paradox in pulmonary arterial hypertension?
Source: International Congress 2017 – Outcomes and new treatment strategies in pulmonary hypertension
Year: 2017
Pathogenesis of pulmonary arterial hypertension: lessons from cancer
Source: Eur Respir Rev 2013; 22: 543-551
Year: 2013
Challenging the concept of adding more drugs in pulmonary arterial hypertension
Source: Eur Respir J, 50 (3) 1701527; 10.1183/13993003.01527-2017
Year: 2017
Iron deficiency in pulmonary arterial hypertension: a potential therapeutic target
Source: Eur Respir J 2011; 38: 1453-1460
Year: 2011
Pulmonary arterial hypertension or left heart disease with pulmonary hypertension? Toward noninvasive clarity, but time for a new paradigm
Source: Eur Respir J 2015; 46: 299-302
Year: 2015
The obesity paradox in pulmonary arterial hypertension: the Scottish perspective
Source: ERJ Open Res, 5 (4) 00241-2019; 10.1183/23120541.00241-2019
Year: 2019
Hypoxic pulmonary vasoconstriction in COPD-associated pulmonary hypertension: been there, done that?
Source: Eur Respir J, 50 (1) 1701191; 10.1183/13993003.01191-2017
Year: 2017
Epigenetic mechanisms in pulmonary arterial hypertension: the need for global perspectives
Source: Eur Respir Rev 2016; 25: 135-140
Year: 2016
The revolution of pulmonary arterial hypertension
Source: Eur Respir Rev 2016; 25: 361-363
Year: 2016
The genetics of pulmonary arterial hypertension
Source: Research Seminar 2005 - Pulmonary Circulation: Molecular Determinants of Pulmonary Vascular Remodelling
Year: 2005
Pulmonary hypertension and pulmonary arterial hypertension: a clarification is needed
Source: Eur Respir J 2010; 36: 986-990
Year: 2010
When is pulmonary hypertension not pulmonary hypertension?
Source: Eur Respir J 2001; 18: Suppl. 33, 522s
Year: 2001
Learning to pair therapies and the expanding matrix for pulmonary arterial hypertension: is more better?
Source: Eur Respir J 2006 Oct 01;28(4):683-686
Year: 2006
The new definition of pulmonary hypertension
Source: Eur Respir J 2009; 34: 790-791
Year: 2009
Novel treatment for pulmonary vascular disease: lessons from pathophysiology
Source: Annual Congress 2006 - Molecular pathology: an approach to lung diseases
Year: 2006
CC6 Is it truly pulmonary arterial hypertension?
Source: Milan 2017 - Educational material
Year: 2017
Smouldering fire or conflagration? An illustrated update on the concept of inflammation in pulmonary arterial hypertension
Source: Eur Respir Rev, 30 (162) 210161; 10.1183/16000617.0161-2021
Year: 2021
Is the increase in NO lung transfer due to free plasmatic hemoglobin in pulmonary arterial hypertension?
Source: International Congress 2015 – Pulmonary hypertension in lung disease
Year: 2015
Autoimmunity and pulmonary arterial hypertension: The role of leptin
Source: Annual Congress 2011 - Experimental pulmonary hypertension
Year: 2011
Contribution of stem-like cells to angioproliferative pulmonary arterial hypertension in the SU5416/chronic hypoxia model
Source: Annual Congress 2012 - Pulmonary circulation: basic mechanisms, animal models and cell biology
Year: 2012
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept